McNicoll Lewis & Vlak Raises PT on AMAG Pharmaceuticals to $23
Tickers: AMAG
McNicoll Lewis & Vlak has raised the price target on AMAG Pharmaceuticals (NASDAQ: AMAG) to $23 and maintains its Buy rating.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Tags: mcnicoll lewis vlak
Posted in: Price Target, Intraday Update, Analyst Ratings